Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate
- Development stage
- Unknown
- Lead developer
- IT3 Medical
- Modality
- Small Molecules
- Administration
- Epidural, Intramuscular, Intravenous, Parenteral, Topical
01
Overview
**Ludaxine** is a co-packaged procedural drug kit containing bupivacaine hydrochloride, dexamethasone sodium phosphate, povidone-iodine, and isopropyl alcohol. Bupivacaine is a long-acting amide local anesthetic that reversibly blocks voltage-gated sodium channels and thereby prevents nerve impulse conduction. Dexamethasone sodium phosphate is a glucocorticoid receptor agonist used as an anti-inflammatory adjunct and may extend local analgesic effects when used with local anesthetic techniques. Povidone-iodine and isopropyl alcohol provide topical antimicrobial skin preparation. DailyMed identifies Ludaxine as a human prescription-drug kit labeled by IT3 Medical and names dexamethasone sodium phosphate plus bupivacaine hydrochloride in its product title. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d19bf48e-b64e-4fe4-82ab-12cb444e92c4))
- Brand names
- Ludaxine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)KCNMA1 (Calcium-activated potassium channel subfamily M alpha member 1)KCNK2 (Potassium channel subfamily K member 2)
Beyond the preview
Go deeper on bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate.